Skip to content

Microbot Medical MBOT Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-27.6%+38.9pp-32.4%+253pp-31.9%+169pp-69.8%+64.7pp-66.5%+120pp
Return on invested capital-33%+45.9pp-39.3%+794pp-37.1%+176pp-89.6%+156pp-78.9%+146pp
Liquidity
Current ratio22.6×+6.4×23.3×+21.0×27.5×+23.9×12.1×+6.7×16.2×+10.3×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$1.10+18.5%$1.69+651%$1.63+603%$0.83+104%$0.93+112%
Valuation
Market capitalization$128.28M+36.1%$134.32M+608%$161.02M+991%$93.13M+472%$52.46M+196%
Price / book1.7×-1.4×1.7×-3.6×2.1×-1.8×3.1×+0.4×1.8×-1.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Microbot Medical's ratios come from?
Every ratio is computed from Microbot Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.